Long-term benefit (LTB) of sunitinib (SU) treatment for metastatic renal cell carcinoma (mRCC): Retrospective analysis for clinical biomarkers identification.
Oren Smaletz
Consultant or Advisory Role - Pfizer
Honoraria - Bayer; Pfizer
Research Funding - Bayer; Novartis; Pfizer; Roche
Matias Chacon
No relevant relationships to disclose
Ludmila de Oliveira Koch
No relevant relationships to disclose
Daniela Regina de Carvalho Rocha
No relevant relationships to disclose
Fernanda Camila Cardoso
No relevant relationships to disclose